Mode
Text Size
Log in / Sign up

Meta-analysis finds sonographic ONSD measurement aids intracranial hypertension detection in emergency settingsA Simple Eye Scan Could Spot a Dangerous Brain Pressure Spike

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider sonographic ONSD as a rapid screening adjunct for intracranial hypertension, recognizing accuracy varies by technique and etiology.

This systematic review and meta-analysis evaluated the diagnostic accuracy of sonographic optic nerve sheath diameter measurement for detecting intracranial hypertension in emergency and critical care settings, using invasive intracranial pressure monitoring as the reference standard. The analysis, which did not report total sample size, identified a critical diagnostic threshold of ONSD ≥5.1 mm. The summary diagnostic accuracy, expressed as a CDEI (composite diagnostic effectiveness index) root node value, was 0.82 (95% CI: 0.79-0.85), with individual study CDEI values ranging from 0.64 to 0.95.

The review found that diagnostic performance improved with specific techniques and operator experience. Multiplanar assessment significantly enhanced prediction of favorable outcomes (CDEI >0.85, p<0.001), and the use of multiplane techniques by experienced operators was associated with a 50% reduction in missed diagnoses (LR- 0.1). When comparing diagnostic thresholds, using a 25 cmH₂O ICP cutoff showed greater specificity (88.4% vs. 82.9%) and a higher positive likelihood ratio (6.5 vs. 5.0) than a 20 mmHg threshold. Diagnostic accuracy also varied by etiology, with nontraumatic brain injury cases showing superior sensitivity (91.9% vs. 85.2%) and a 107% higher diagnostic odds ratio (63.3 vs. 30.5) compared to traumatic cases.

Safety and tolerability data for the sonographic procedure were not reported. Key limitations include the lack of reported total sample size and follow-up duration, heterogeneity in measurement techniques and population demographics across included studies, and the absence of absolute numbers for many outcomes. The evidence suggests sonographic ONSD measurement, particularly when performed with multiplanar techniques by experienced operators, may provide useful adjunctive information for rapid bedside assessment of suspected intracranial hypertension. However, given the observational nature of the evidence and variability in reported accuracy, it should not replace invasive ICP monitoring when definitive measurement is clinically indicated.

A Simple Eye Scan Could Spot a Dangerous Brain Pressure Spike

  • The Big Discovery: An ultrasound scan of the eye can accurately detect dangerous pressure building inside the skull.
  • Who it helps: Patients with head injuries, strokes, or brain bleeds in emergency settings.
  • The Catch: It's a promising screening tool, but not yet a replacement for gold-standard tests in all hospitals.

The condition is called intracranial hypertension (ICH). It means the pressure inside the skull is too high.

This pressure can crush delicate brain tissue. It is a medical emergency that can lead to permanent brain damage or death.

ICH can happen after a traumatic brain injury, a major stroke, or a brain bleed. Currently, the only way to know the pressure for sure is to place a monitor directly into the brain. This involves drilling a small hole in the skull.

It’s a procedure that carries risk. It also requires specialized neurosurgeons and intensive care units. In many hospitals, especially in remote areas, this isn’t immediately available.

Doctors have needed a faster, safer way to screen for this silent threat.

The Surprising Shift

For years, doctors have known a fascinating fact: the optic nerve, which connects your eye to your brain, is like a soft cable. It’s surrounded by fluid that is directly connected to the fluid around your brain.

When pressure rises in the skull, it pushes that fluid down the nerve sheath—the protective tube around it. This causes the sheath to swell, like a garden hose filling with water.

Scientists wondered if they could measure that swelling from the outside. They turned to ultrasound, the same safe, radiation-free technology used to look at babies in the womb.

The idea was promising. But results from early studies were mixed. Was it accurate enough? Where exactly should you measure? What number signals true danger?

This new research, a major analysis of 35 previous studies, finally provides clear answers.

Think of your skull as a rigid, sealed box. Inside is your brain, bathed in fluid. If the brain swells from an injury or bleeds, pressure inside the box skyrockets because there’s nowhere for it to go.

The optic nerve sheath is one of the only soft, stretchable pathways out of that box. The high-pressure fluid gets pushed down this narrow channel.

An ultrasound probe placed gently on a patient’s closed eyelid can see this. Doctors look for a tell-tale thickening of the nerve’s sheath. It’s a direct window into the pressure of the brain itself.

Researchers analyzed data from thousands of patients suspected of having high brain pressure. They compared ultrasound eye measurements to the invasive monitor readings.

The goal was to find a single, reliable number that signals danger.

The Magic Number

The analysis pinpointed a critical threshold. An optic nerve sheath diameter of 5.1 millimeters or larger was a strong indicator of high intracranial pressure.

But the technique matters. The study found that taking measurements from multiple angles (a multiplanar technique) was far more accurate than a single view.

This doesn’t mean this tool is ready for use in every clinic tomorrow.

When done this better way, by an experienced operator, the test became extremely reliable. It correctly identified most patients with high pressure (high sensitivity) and rarely mislabeled healthy patients as sick (high specificity).

Interestingly, the scan worked even better for patients with non-traumatic causes, like a severe stroke or infection, than for those with traumatic brain injuries.

The Expert Perspective

This meta-analysis acts as a much-needed guidebook. It moves the technique from a curious idea toward a standardized clinical tool.

By pooling global data, it clarifies the "how" and the "when." The findings suggest this isn't just a research trick. It has real potential to change decision-making in hectic emergency rooms and intensive care units.

If you or a family member is ever in a neurological crisis, this research is paving the way for faster, safer screening.

The eye ultrasound is painless, takes minutes, and has no radiation. It could help doctors decide who needs immediate, invasive monitoring and who can be watched closely without it.

However, it is crucial to know this is a screening tool, not a final diagnosis. It helps rule in or rule out the need for further, more definitive tests. Always follow the treatment plan set by your medical team.

Understanding the Limits

This is an analysis of existing studies, not a new clinical trial. While powerful, it shows what is possible under research conditions.

Real-world accuracy depends heavily on the skill of the person performing the scan and the specific equipment used. Hospitals do not yet have a universal, standardized protocol for this measurement.

The next critical step is large, multicenter trials to validate these findings in everyday hospital settings. Medical societies will need to agree on official guidelines and training for clinicians.

The researchers also identified a potential warning sign: a sheath diameter around 6.0 mm may predict poorer patient outcomes, opening another vital path for study.

The journey from research to bedside takes time and rigorous testing. But this analysis provides a strong, clear signal that looking into the eye may soon be a standard way to protect the brain.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
OBJECTIVES: In this study, we aimed to assess the clinical efficacy of sonographic optic nerve sheath diameter (ONSD) measurements for detecting intracranial hypertension (ICH). Our objectives included evaluating its diagnostic precision compared with invasive intracranial pressure (ICP) monitoring; exploring potential sources of heterogeneity, such as measurement technique (multi vs. single-planar), population demographics (Asian vs. non-Asian), and major etiologies; and determining validated thresholds for prompt bedside ICP assessment in acute neurological crises. DATA SOURCES: We comprehensively searched eight databases, including four in English (PubMed, Web of Science, MEDLINE®, and Embase) and four in Chinese (China National Knowledge Infrastructure [CNKI], Wanfang, VIP, and SinoMed). The search covered literature published from the inception of the databases up to May 31, 2025. STUDY SELECTION: This review includes prospective, retrospective, and case-control studies that assess the efficacy of sonographic ONSD measurement for detecting ICH, defined as an ICP exceeding 20 mm Hg, 20 cmHO, 25 cmHO with invasive ICP measurement as the gold standard. DATA EXTRACTION: X.T. and Q.T. independently screened the studies and assessed the risk of bias using the QUADAS-2 tool. STATISTICAL ANALYSIS: Diagnostic accuracy was pooled using a bivariate random-effects model to generate summary receiver operating characteristic (SROC) curves. Subgroup analyses of the measurement technique, study population, and etiology were conducted. Publication bias was assessed using Deeks' test. DATA SYNTHESIS: The decision tree analysis revealed that an ONSD ≥ 5.1 mm is the critical diagnostic threshold for detecting intracranial hypertension. The regression tree model indicated a range of CDEI values from 0.64 to 0.95, with a root node value of 0.82 (95% CI: 0.79-0.85). The incorporation of a multiplanar assessment significantly enhanced the prediction of favorable outcomes (CDEI > 0.85; p < 0.001). Moreover, compared with a 20 mmHg threshold, a 25 cmH₂O threshold resulted in greater specificity (88.4% vs. 82.9%) and a higher positive likelihood ratio (LR+ 6.5 vs. 5.0). The utilization of multiplane techniques and experienced operators notably improved diagnostic accuracy, leading to a 50% reduction in missed diagnoses (LR- 0.1). Nontraumatic brain injury cases exhibited superior sensitivity (91.9% vs. 85.2%) and a 107% higher diagnostic odds ratio (63.3 vs. 30.5) than traumatic brain injury cases did. CONCLUSIONS: Findings from this study suggest that an ONSD threshold ≥ 5.1 mm is a promising diagnostic marker for elevated ICP (> 20 cmH₂O/mmHg or acute etiology), although external validation is needed. A multiplane evaluation improves its predictive accuracy for favorable outcomes. The developed decision model supports the use of sonographic ONSD measurement as a supplementary screening tool in emergency and critical care, particularly when invasive monitoring is unavailable. Additionally, an ONSD of approximately 6.0 mm is a potential prognostic indicator for unfavorable outcomes, highlighting a key area for future research. These findings can only be applied after their validation through multicenter studies and the establishment of standardized measurement protocols.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.